Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742091).
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002): Complete Statistical AnalysisIndependent statistical analysis of A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate…
- A Multiple-dose Study of LY3031207 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Multiple-dose Study of LY3031207 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632566).
- A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold: Complete Statistical AnalysisIndependent statistical analysis of A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy: Complete Statistical AnalysisIndependent statistical analysis of A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®: Complete Statistical AnalysisIndependent statistical analysis of A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01913353).
- A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy: Complete Statistical AnalysisIndependent statistical analysis of A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Non-Interventional Study To Assess Sweating: Complete Statistical AnalysisIndependent statistical analysis of A Non-Interventional Study To Assess Sweating: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02552199).
- A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1): Complete Statistical AnalysisIndependent statistical analysis of A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache: Complete Statistical AnalysisIndependent statistical analysis of A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01899040).
- A Novel Approach for Brain Stimulation in Severe Stroke: Complete Statistical AnalysisIndependent statistical analysis of A Novel Approach for Brain Stimulation in Severe Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03868410).
- A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.: Complete Statistical AnalysisIndependent statistical analysis of A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06481150).
- A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval,…
- A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1: Complete Statistical AnalysisIndependent statistical analysis of A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1: primary endpoint results,…
- A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1): Complete Statistical AnalysisIndependent statistical analysis of A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive…
- A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians: Complete Statistical AnalysisIndependent statistical analysis of A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD): Complete Statistical AnalysisIndependent statistical analysis of A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use: Complete Statistical AnalysisIndependent statistical analysis of A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer: Complete Statistical AnalysisIndependent statistical analysis of A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose RoActemra/Actemra (Tocilizumab) in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose RoActemra/Actemra (Tocilizumab) in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03303911).
- A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01702519).
- A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007): Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01626859).
- A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03085836).
- A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected…
- A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years…
- A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate…
- A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris: primary endpoint results, effect estimate with confidence…
- A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: primary endpoint…
- A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202): Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202): primary endpoint results, effect estimate with confidence interval,…
- A Phase 2 Study For Patients With A Physician’s Diagnosis Of Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma: primary endpoint results, effect estimate with confidence…
- A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…